Our Team



<< < 1 2

Paul Lepage


Paul Lepage, B.Eng., MBA, Dr. h.c.


President and CEO, Intelerad Medical Systems


Mr. Lepage spearheads Intelerad Medical Systems’s mission to make a difference in healthcare by providing high-performance, scalable and reliable cloud-based medical imaging solutions for healthcare providers worldwide. His vision: help Intelerad become the cloud imaging platform of choice for large scale imaging providers by harnessing his team’s 20 years of expertise in the field and innovations such as machine learning and cloud computing to enable customers to work smarter and drive better health outcomes.


Before joining Intelerad Medical Systems, Paul led TELUS Health for nine years and its mission to harness the power of information technology for better health care. In doing so, he significantly expanded TELUS Health’s position as the leading organization in healthcare IT in Canada.


Mr. Lepage draws on more than 30 years of experience in the health telecommunications and information technology sectors. In 2009, he was the President and CEO of MediSolution Ltd., a leader in the North American IT industry. Prior to this, he held various leadership roles, including Chief Marketing Officer, Chief Operating Officer and head of Global Sales for several major technology companies.


Since 2016, Paul has also managed TELUS Ventures, the venture capital arm of TELUS. The branch specializes in strategic investments in market opportunities whose innovations have the potential to accelerate the growth of TELUS, particularly in the area of health.


Mr. Lepage has an MBA from Concordia University and a Bachelor of Engineering from Polytechnique Montréal. In 2016, Polytechnique honoured his extensive contribution to Health IT in Canada and the engineering profession with an honorary doctorate.


He currently serves on the board of Génome Québec and is a member of the StradigiAI advisory board. Previous board mandates include Montréal InVivo and TOHealth! As well as on the advisory board of Edmonton: Canada’s Health City in Alberta. He also previously sat on the board of directors of Get Real Health in the United States, the Quebec Technology Association, IBWave, Nova Expertise Solutions, MediSolution and Blue Streak Technologies, as well as being a member of the Montreal Community Board of TELUS. Paul has also leveraged his expertise on committees for organizations such as CEFRIO, the Sandbox Project, the Ivey international Centre for Health Innovation and the Juvenile Diabetes Research Foundation, where he also acted as honorary president and national campaign manager for several years. He has received the ICD.D certification granted by the Institute of Corporate Directors.


Sylvain Moineau


Sylvain Moineau, O.C., PhD, FRSC


Full Professor
Département de biochimie, de microbiologie et de bio-informatique
Université Laval

Professor Sylvain Moineau completed a Bachelor of Microbiology at Université Laval in 1987. He pursued his academic career at the same university and, in 1993, earned a PhD in Food Science. During his PhD, he also spent 18 months at North Carolina State University. He then pursued industrial postdoctoral work with Unilever, the Florida-based multinational.

 

In 1996, he returned to Université Laval as Assistant Professor in microbiology, where his research team studies the biology of phages and phage-resistance mechanisms, including work on CRISPR-Cas systems. In 2005, he earned his full professorship and he is now a Professor in the Department of Biochemistry, Microbiology and Bioinformatics at Université Laval.

 

He holds the Canada Research Chair in Bacteriophages and is the Curator of the Félix d’Hérelle Reference Center for Bacterial Viruses, the world largest collection of reference phages : www.phage.ulaval.ca.

 

His research group studies phage biology and phage-bacteria interactions. Among others, he has characterized mechanisms used by bacteria to resist phages, including his landmark work on CRISPR-Cas systems.

 

Prof. Moineau has won several teaching and research awards. In 2017, he was awarded the NSERC John C. Polanyi Award, the Canadian Society of Microbiologists Murray Award for Career Achievement and the DuPont Excellence Medal. He was elected to the Academy of Sciences of the Royal Society of Canada and appointed an Officer of the Order of Canada. Thomson Reuters and Clarivate Analytics have ranked him amongst the most cited microbiologists for the past five years.


Rémi Quirion


Rémi Quirion, PhD, CQ, O.C., FRSC


Chief Scientist of Québec

 

Professor Rémi Quirion is Chief Scientist of Québec following the implementation of Bill 130 on July 1, 2011, which merged Québec’s three research funds. A full professor in McGill’s Department of Psychiatry, Professor Quirion served as Scientific Director at the Douglas Mental Health University Institute from 1996 to 2011. In April 2009, he took up the position of Vice Dean (Life Sciences and Strategic Initiatives), Faculty of Medicine, as well as Senior University Advisor (Health Sciences Research) at McGill University, in addition to serving as the CIHR Executive Director, International Collaborative Research Strategy for Alzheimer's Disease. He withdrew from these positions following his nomination as Québec’s Chief Scientist.

 

Since 1996, under his leadership, the Douglas Research Centre became a premier research facility in Canada in the fields of neurosciences and mental health. Professor Quirion promoted the development of neurosciences and clinical research in neurology and psychiatry, as well as the social aspects and evaluation of research in mental health and addiction. His research interests include: a) understanding the relationships between key phenotypes of the Alzheimer's brain and b) molecular and pharmacological features of neuropeptide receptors focusing on NPY and CGRP, and their role in memory, pain and drug dependence, and in animal models of schizophrenia.He has a keen interest for training the next generation of scientists, having mentored over 20 doctoral students and 50 postdoctoral students, who currently work around the world. In addition to sitting on the advisory boards of over 15 scientific journals in psychiatry, pharmacology, and neurosciences, Professor Quirion has published 5 books, over 600 scientific papers and articles.

 

From 2000 to 2009, Professor Quirion was the first Scientific Director of the Institute of Neurosciences, Mental Health and Addiction (INMHA), one of the 13 virtual institutes of the Canadian Institutes of Health Research created in 2000. He is also one of the most highly cited neuroscientists in the world and a Fellow of the Royal Society of Canada. In 2003, he was named “Chevalier” of the Ordre national du Québec and received the Médaille de l’Assemblée nationale du Québec and the First Annual Award – National Mental Health Champion (Research). In 2004, he was honoured with the Québec Wilder-Penfield Award, the highest distinction in biomedical research in Québec as well as the Heinz Lehmann Award of the Douglas Hospital Foundation and the Dr. Mary V. Seeman Award from the Canadian Psychiatric Research Foundation. In 2005, he was appointed Fellow of the Canadian Academy of Health Sciences here at home and awarded an Honoris Causa Doctorate from the Central South University of China, Changsha, Hunan, which ranks among the country’s top 15 universities out of 2000; he also became a member of this university’s Academic Committee, a mandate that lasted until December 2010.

 

In 2007 Professor Quirion became a Member of the Order of Canada (O.C.) in recognition of his prolific scientific career. His latest distinctions include the Schizophrenia Society of Canada’s 2007 Pacesetter Award; the Canadian College of Neuropharmacology 2007 Medal for his exemplary career and exceptional contribution to neuropsychopharmacology in Canada through training, education and administration; the 2007 Prix Michel Sarrazin of the Club de recherches cliniques du Québec and the Verdun “Tip of the Hat” prize for international distinction awarded by the Verdun Economic Forum. In 2010 Professor Quirion was honoured with an Honoris Causa Doctorate from the Institut National de la Recherche in Québec City and in 2011 received yet another Honoris Causa Doctorate, Honorary Doctor of Laws, this time from Montréal’s Concordia University.


François R. Roy


François R. Roy


Corporate Director


François R. Roy has extensive experience as a corporate director and executive in the public and private sectors, on the boards of various non-profit organizations and in academia. He started his career at Scotia Bank, where he held various positions in Canada and in the US, and then later for the Société générale de financement du Québec. Mr. Roy has worked as Chief Financial Officer for Québecor, Avenor and Telemedia Corporation. He has also served on boards of directors since 1998 and currently sits on the board of Transcontinental, Noranda Income Fund, Capstone Infrastructure Corporation, Ovivo Inc. and the Caisse de dépôt et placement du Québec. From 2007 to 2010, he was the Chief Financial Officer at McGill University.

 

Mr. Roy holds a Bachelor of Arts and Master of Business Administration from the University of Toronto. For the past 25 years, he has been actively involved with many non-profit organizations, such as the Montreal Museum of Fine Arts, Canadian Centre for Architecture, Vie des Arts magazine, Opéra de Montréal, Collège Jean-Eudes, Council for Canadian American Relations and Montreal International Music Competition.


Jennifer Stoddart


Jennifer Stoddart, O.C., Ad. É.


Invited Scholar, Centre of Genomics and Policy, McGill University


Jennifer Stoddart was Canada’s privacy commissioner from December 2003 until December 2013. Early in her mandate, she recognized that to remain relevant as Canada’s privacy guardian, the Office of the Privacy Commissioner of Canada needed to focus attention on the online world. She also worked to raise awareness among Canadians of their privacy rights through enhanced communications, outreach, and research activities. Recognizing Canada’s international trade patterns, she also became involved in global privacy issues through her work with international organizations such as the OECD and the Asia-Pacific Economic Cooperation, which are examining ways to protect and enhance privacy rights on a global scale.

 

Jennifer Stoddart was the 2010 recipient of the International Association of Privacy Professionals’ Privacy Vanguard Award, and in June 2011, the Québec Bar awarded her the distinctions of Avocat émérite and Mérite Christine-Tourigny. She also received the Ontario Bar Association’s 2010 Karen Spector Memorial Award for Excellence in Privacy Law, and in 2009, she was awarded the Université du Québec à Montréal’s Prix Reconnaissance for her work protecting the privacy rights of Canadians. In 2012, the Washington-based Electronic Privacy Information Center awarded her its International Privacy Champion Award, and in 2011, Canadian Lawyer magazine named Jennifer Stoddart to its list of the “Top 25 Most Influential” in the justice system and legal profession in Canada. 


Ms. Stoddart was appointed Officer of the Order of Canada in December 2015, “for her international leadership in privacy rights and for her exemplary public service as the privacy commissioner of Canada.”

 
Jennifer Stoddart has served on the steering committee of the Group of Heads of Federal Agencies, a network comprising the chief executive officers of more than 100 federal agencies, boards, commissions, tribunals and Crown corporations. She also presided the Commission d’accès à l’information du Québec. While in this position, she published a report entitled The Choice of Transparency that led to important changes to Québec’s access to information and data protection legislation mandating that government departments and agencies make more information available to citizens. She has held several senior positions in public administration for the Governments of Québec and Canada since being called to the Québec Bar in 1981.

 
Ms. Stoddart holds a bachelor of civil law degree from McGill University, a master of arts in history from the University of Québec at Montréal, and a bachelor of arts from the University of Toronto’s Trinity College.


Suzanne Vinet


Suzanne Vinet


Suzanne Vinet retired from the federal public service in April 2014. She began her career as a public servant in 1984 with the Department of Agriculture and Agri-Food Canada, where she gained extensive expertise in strategic and trade policy. In recent years, she has held several senior positions:

  • Deputy Minister, Agriculture and Agri-Food Canada (2012-2014)
  • President, Canada Economic Development for Quebec Regions (2010-2012)
  • Associate Deputy Minister, Transport, Infrastructure and Communities (2009-2010)
  • Associate Deputy Minister, Health Canada (2007-2009)
  • Assistant Deputy Minister, Strategic Policy, Agriculture and Agri-Food Canada (2005-2007)
  • Director General, Trade Policy, International Trade / and Deputy Chief Negotiator-World Trade Organization, Department of Foreign Affairs and International Trade (2002-2005)
  • Director General, International Trade Policy and Chief Negotiator-World Trade Organization, Agriculture and Agri-Food Canada (2000-2002)

 

A native of Vaudreuil, Québec, Ms. Vinet holds a Bachelor of Arts Degree (Economics) from Wilfrid Laurier University in Waterloo, and received a diploma from the Institut de Technologie agricole et alimentaire in Saint-Hyacinthe. She also attended the National Defence College of Canada in Kingston.


<< < 1 2